Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
A major makeover is underway at a former AbbVie biologics plant in England, which Pharmaron purchased for $119 million in 2021.
BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) today announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022. The UK Chemistry, Manufacturing and Control (CMC) business includes operations in Hoddesdon and Cramlington, UK.
Recipharm has sold the solid dose manufacturing site at Fontaine-lès-Dijon, France to Astrea Pharma, the newly established contract development and manufacturing organization ( CDMO ) focused on small molecule oral solid and aseptic dosages.
BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm group.